Semaglutide 5mg
Semaglutide in a convenient pen — precise dosing without compromise. GLP-1 receptor agonist.
Choose a variant
This product is intended exclusively for laboratory and research purposes. Not intended for direct use or human consumption. For persons over 18 years of age only.
About the product
Semaglutide in the form of an injection pen — a GLP-1 receptor agonist intended for research into metabolism and glycemic regulation.
The product is available as a 5 mg pre-filled pen with a precise dosing mechanism. Purity verified by HPLC.
Composition & specifications
The information below is for reference only and is intended exclusively for research purposes. It is not medical advice.
In clinical research, the starting dose was 0.25 mg once weekly subcutaneously for 4 weeks.
Increase to 0.5 mg weekly. Titration minimizes gastrointestinal side effects.
Clinically tested doses of 1–2 mg weekly according to the research protocol and monitored parameters.
Subcutaneous injection; rotate the injection site.
Upon receiving the shipment, place the product in a refrigerator immediately (2–8 °C). Do not freeze.
Protect from direct sunlight and heat sources. Keep in the original sealed packaging.
When stored correctly, the product is stable for the period indicated on the packaging. Use according to batch specification after opening.
How long is the pen stable after opening?
Can the pen be carried outside the fridge?
Other products
